Yan Wu

ORCID: 0000-0002-8966-4975
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acupuncture Treatment Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Ovarian function and disorders
  • Reproductive Biology and Fertility
  • Growth Hormone and Insulin-like Growth Factors
  • CAR-T cell therapy research
  • Healthcare and Venom Research
  • Retinal Diseases and Treatments
  • Cancer, Hypoxia, and Metabolism
  • PI3K/AKT/mTOR signaling in cancer
  • Cancer Research and Treatments
  • Monoclonal and Polyclonal Antibodies Research
  • Complementary and Alternative Medicine Studies
  • interferon and immune responses
  • Cytokine Signaling Pathways and Interactions
  • Systemic Lupus Erythematosus Research
  • Glycosylation and Glycoproteins Research
  • Chronic Lymphocytic Leukemia Research
  • Cancer-related molecular mechanisms research
  • Birth, Development, and Health
  • Chemokine receptors and signaling
  • Multiple Sclerosis Research Studies
  • Cancer-related gene regulation
  • Synthesis and biological activity
  • HER2/EGFR in Cancer Research

Northeast Forestry University
2024-2025

Anhui University of Traditional Chinese Medicine
2023-2024

Harrison International Peace Hospital
2023-2024

Second Affiliated Hospital of Zhejiang University
2024

Zhejiang University
2014-2024

Zhejiang Lab
2024

Anhui University
2024

Obstetrics and Gynecology Hospital of Fudan University
2023-2024

Women's Hospital, School of Medicine, Zhejiang University
2007-2023

The First Affiliated Hospital, Sun Yat-sen University
2023

Objective Endometriosis is a common benign disease in women of reproductive age. Qu’s formula (QUF) patented Chinese herbal medicine for treating endometriosis that has been proven to be effective and preventing the recurrence endometriosis. This study aimed discover its molecular mechanism explore potential drug targets. Methods A QUF target endometriosis-related gene set was identified by Traditional Medicine Systems Pharmacology (TCMSP) Bioinformatics Analysis Tool Molecular Mechanism...

10.1371/journal.pone.0263614 article EN cc-by PLoS ONE 2022-02-07

The aim was to determine preoperative gut microbiota metabolites that may be associated with postoperative delirium (POD) development in patients and further study rodents.POD occurs 9% 50% of older undergoing anesthesia/surgery but lacks effective treatments or prevention. High-throughput metabolomics using liquid chromatography tandem mass spectrometry has accelerated disease-related biomarkers discovery. We performed metabolomic studies humans identify potential metabolite linked POD...

10.1097/sla.0000000000005886 article EN cc-by Annals of Surgery 2023-04-27

Abstract Background Venetoclax (Ven) combined with intensive chemotherapy was proven effective in the management of acute myeloid leukemia (AML). However, severe and prolonged myelosuppression remains a concern to worry about. To explore more appropriate combination regimens, we designed Ven combining daunorubicin cytarabine (DA 2 + 6) regimen as induction therapy, aimed evaluate effectiveness safety adults de novo AML. Methods A phase clinical trial performed 10 Chinese hospitals...

10.1186/s40164-023-00409-y article EN cc-by Experimental Hematology and Oncology 2023-05-12
Coming Soon ...